-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Keros Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2019 to Q3 2024.
- Keros Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$58.7M, a 35.5% decline year-over-year.
- Keros Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$204M, a 31.3% decline year-over-year.
- Keros Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$170M, a 48% decline from 2022.
- Keros Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$115M, a 104% decline from 2021.
- Keros Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$56.4M, a 20.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)